Medtronic and Apollo Hospitals to establish state-of-the-art advanced ICU in Hyderabad

Medtronic, a global leader in healthcare technology, and Apollo Hospitals have announced the inauguration of “ICU of the Future” an 11-bed, state-of-the-art Intensive Care Unit (ICU) at Apollo Hospitals, Jubilee Hills.

The new facility will be fully integrated with Medtronic’s advanced Acute Care & Monitoring (ACM) technologies and solutions, marking a significant milestone in collaborative healthcare innovation.

The MoU was officially signed by Dr Sangita Reddy, Joint Managing Director, Apollo Hospitals Group; Manpreet Singh, Chief Executive Officer, Apollo HealthAxis and Mandeep Singh Kumar, Managing Director & Vice President – India Subcontinent Countries, Medtronic during a formal inauguration ceremony held at the Jubilee Hills campus.

Developed in collaboration with Medtronic’s ACM team, the initiative represents a step forward in strengthening critical care infrastructure and advancing collaborative healthcare innovation.

The integrated ICU is designed to support evolving clinical needs while fostering closer collaboration between clinicians and technology leaders. By bringing together clinical expertise and advanced technologies, the collaboration aims to help enable more informed care delivery and contribute to improved patient outcomes.

Mandeep Singh Kumar, Vice President – India Subcontinent Countries, Medtronic said, “This advanced ICU at Apollo Hospitals reflects a shared commitment to patient care and clinical excellence. Through this collaboration, we aim to gain valuable insights from real-world clinical environment that can help inform the development of technologies designed to support clinicians and improve patient care in India and around the world.”

Dr Sangita Reddy, Joint Managing Director, Apollo Hospitals Group said, “Critical care is where every decision, every minute and every intervention can make the difference between life and loss. As medicine becomes increasingly data-driven, our responsibility is not only to bring the best technologies to India but to ensure they meaningfully improve clinical decisions and patient outcomes."